Role of PCSK9 in lipid metabolic disorders and ovarian dysfunction in polycystic ovary syndrome-Reference-Cited by-同舟云学术

Role of PCSK9 in lipid metabolic disorders and ovarian dysfunction in polycystic ovary syndrome

Published:2019-05 Issue: Volume:94 Page:47-58
ISSN:0026-0495
Container-title:Metabolism
language:en
Short-container-title:Metabolism

Author:

Wang Meijiao,Zhao Dan,Xu Liangzhi,Guo Wenjing,Nie Li,Lei Yi,Long Yun,Liu Min,Wang Yichen,Zhang Xueqin,Zhang Li,Li Hanna,Zhang Jinhu,Yuan Dongzhi,Yue Limin

Funder

National Natural Science Foundation of China

Sichuan Natural Science Foundation

Fundamental Research Funds for the Central Universities

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Reference40 articles.

1. The polycystic ovary syndrome: a position statement from the European Society of Endocrinology;Conway;Eur J Endocrinol,2014

2. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS);Rotterdam EA-SPcwg;Hum Reprod,2004

3. Proprotein convertase subtilisin/kexin type 9 (PCSK9) and metabolic syndrome: insights on insulin resistance, inflammation, and atherogenic dyslipidemia;Ferri;Endocrine,2016

4. Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome;Legro;Am J Med,2001

5. Dyslipidemia in women with polycystic ovary syndrome: incidence, pattern and predictors;Rocha;Gynecol Endocrinol,2011

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SFRP4 contributes to insulin resistance-induced polycystic ovary syndrome by triggering ovarian granulosa cell hyperandrogenism and apoptosis through the nuclear β-catenin/IL-6 signaling axis;Biochimica et Biophysica Acta (BBA) - Molecular Cell Research;2024-10

2. Hormonal and Physiological Manipulation Methods to Induce Polycystic Ovary in Rodents: A Review of the New Findings;OBM Genetics;2024-07-04

3. The role of natural products as PCSK9 modulators: A review;Phytotherapy Research;2024-06-20

4. Rhythm gene PER1 mediates ferroptosis and lipid metabolism through SREBF2/ALOX15 axis in polycystic ovary syndrome;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-06

5. Inhibition of PCSK9 prevents and alleviates cholesterol gallstones through PPARα-mediated CYP7A1 activation;Metabolism;2024-03